Sorrento Therapeutics, Inc. COMMON STOCK SALES AGREEMENTSales Agreement • April 27th, 2020 • Sorrento Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledApril 27th, 2020 Company Industry Jurisdiction
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • April 27th, 2020 • Sorrento Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledApril 27th, 2020 Company Industry JurisdictionCOMMON STOCK PURCHASE AGREEMENT (the “Agreement”), dated as of April 27, 2020 by and between SORRENTO THERAPEUTICS, INC., a Delaware corporation (the “Company”), and Arnaki Ltd., a British Virgin Islands corporation (including its successors and assigns, the “Purchaser”). Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.